[Comparison of clinical efficacy and quality of life between uncut Roux-en-Y and Billroth II with Braun anastomosis in laparoscopic distal gastrectomy for gastric cancer]
- PMID: 35176829
- DOI: 10.3760/cma.j.cn441530-20210702-00257
[Comparison of clinical efficacy and quality of life between uncut Roux-en-Y and Billroth II with Braun anastomosis in laparoscopic distal gastrectomy for gastric cancer]
Abstract
Objective: To compare the clinical efficacy and quality of life between uncut Roux-en-Y and Billroth II with Braun anastomosis in laparoscopic distal gastrectomy for gastric cancer patients. Methods: A retrospective cohort study was performed. Inclusion criteria: (1) 18 to 75 years old; (2) gastric cancer proved by preoperative gastroscopy, CT and pathological results and tumor was suitable for D2 radical distal gastrectomy; (3) postoperative pathological diagnosis stage was T1-4aN0-3M0 (according to the AJCC-7th TNM tumor stage), and the margin was negative; (4) Eastern Cooperative Oncology Group (ECOG) physical status score <2 points, and American Association of Anesthesiologists (ASA) grade 1 to 3; (5) no mental illness; (6) able to answer questionnaires independently; (7) patients agreed to undergo laparoscopic distal gastrectomy and signed an informed consent. Exclusion criteria: (1) patients with severe chronic diseases and American Association of Anesthesiologists (ASA) grade >3; (2) patients with other malignant tumors; (3) patients suffered from serious mental diseases; (4) patients received neoadjuvant chemotherapy or immunotherapy. According to the above criteria, clinical data of 200 patients who underwent laparoscopic distal gastrectomy at the Department of General Surgery of the First Affiliated Hospital of Army Medical University from January 2016 to December 2019 were collected. Of the 200 patients, 108 underwent uncut Roux-en-Y anastomosis and 92 underwent Billroth II with Braun anastomosis. The general data, intraoperative and postoperative conditions, complications, and endoscopic evaluation 1 year after the surgery were compared. Besides, the quality of life of two groups was also compared using the Chinese version of the European Organization For Research and Treatment of Cancer (EORTC) quality of life questionnaire-Core 30 (QLQ-C30) and quality of life questionnaire-stomach 22 (QLQ-STO22). Results: There were no significant differences in baseline data between the two groups (all P>0.05). All the 200 patients successfully underwent laparoscopic distal gastrectomy without intraoperative complications, conversion to open surgery or perioperative death. There were no significant differences between two groups in operative time, intraoperative blood loss, postoperative complications, time to flatus, time to removal of gastric tube, time to liquid diet, time to removal of drainage tube or length of postoperative hospital stay (all P>0.05). Endoscopic evaluation was conducted 1 year after surgery. Compared to Billroth II with Braun group, the uncut Roux-en-Y group had a significantly lower incidences of gastric stasis [19.8% (17/86) vs. 37.0% (27/73), χ(2)=11.199, P=0.024], gastritis [11.6% (10/86) vs. 34.2% (25/73), χ(2)=20.892, P<0.001] and bile reflux [1.2% (1/86) vs. 28.8% (21/73), χ(2)=25.237, P<0.001], and the differences were statistically significant. The EORTC questionnaire was performed 1 year after surgery, there were no significant differences in the scores of QLQ-C30 scale between the two groups (all P>0.05), while the scores of QLQ-STO22 showed that, compared to the Billroth II with Braun group, the uncut Roux-en-Y group had a lower pain score (median: 8.3 vs. 16.7, Z=-2.342, P=0.019) and reflux score (median: 0 vs 5.6, Z=-2.284, P=0.022), and the differences were statistically significant (all P<0.05), indicating milder symptoms. Conclusion: The uncut Roux-en-Y anastomosis is safe and reliable in laparoscopic distal gastrectomy, which can reduce the incidences of gastric stasis, gastritis and bile reflux, and improve the quality of life of patients after surgery.
目的: 比较腹腔镜远端胃癌根治术非离断Roux-en-Y吻合与毕Ⅱ+Braun吻合的临床疗效和生活质量。 方法: 采用回顾性队列研究方法。病例纳入标准:(1)年龄18~75岁;(2)术前经胃镜、CT及病理活检证实为胃癌,需行D(2)根治性远端胃大部切除术;(3)术后病理诊断分期为T(1~4)aN(0~3)M(0),切缘阴性;(4)美国东部肿瘤协作组(ECOG)体力状态评分<2分,美国麻醉医师协会(ASA)分级为1~3级;(5)无精神疾病;(6)能独立回答问卷;(7)同意行腹腔镜手术并签署知情同意书。排除标准:(1)合并严重慢性基础疾病,美国麻醉医师协会(ASA)分级>3级;(2)合并其他恶性肿瘤;(3)有严重精神疾病;(4)患者已进行新辅助化疗、免疫治疗等。根据以上标准,回顾性收集2016年1月至2019年12月期间,陆军军医大学第一附属医院普通外科收治的200例行腹腔镜远端胃癌根治术患者的临床资料,其中非离断Roux-en-Y吻合组108例、毕Ⅱ+Braun吻合组92例。比较两组患者的一般资料、术中术后情况、并发症情况以及术后1年胃镜检查情况,并采用中文版欧洲癌症研究与治疗组织(EORTC)设计的生活质量核心量表(QLQ-C30)以及胃癌特异性模块量表(QLQ-STO22)比较两组患者术后生活质量情况。 结果: 两组患者基线资料比较,差异均无统计学意义(均P>0.05)。200例患者均成功进行腹腔镜远端胃癌根治术,无术中并发症发生,无中转开腹,无围手术期死亡病例。两组患者手术时间、术中出血量、术后并发症发生情况、术后排气时间、拔胃管时间、进流食时间、拔引流管时间、术后住院时间比较差异均无统计学意义(均P>0.05)。术后1年胃镜复查,相比毕Ⅱ+Braun吻合组,非离断Roux-en-Y吻合组的食物潴留发生率[19.8%(17/86)比37.0%(27/73),χ(2)=11.199,P=0.024]、残胃炎发生率[11.6%(10/86)比34.2%(25/73),χ(2)=20.892,P<0.001]、胆汁反流发生率[1.2%(1/86)比28.8%(21/73),χ(2)=25.237,P<0.001]均更低,差异均具有统计学意义。两组患者术后1年QLQ-C30量表评分显示,各项评分差异均无统计学意义(均P>0.05);而QLQ-STO22量表评分显示,相比毕Ⅱ+Braun吻合组,非离断Roux-en-Y吻合组的疼痛症状(中位数:8.3分比16.7分,Z=-2.342,P=0.019)和反流症状(中位数:0分比5.6分,Z=-2.284,P=0.022)更轻,差异有统计学意义(均P<0.05)。 结论: 非离断Roux-en-Y吻合在腹腔镜远端胃癌根治术中安全可靠,能够减少食物潴留、残胃炎及胆汁反流,改善患者术后生活质量。.
Keywords: Billroth II with Braun anastomosis; Clinical efficacy; Distal gastrectomy; Laparoscopy; Quality of life; Stomach neoplasms; Uncut Roux-en-Y.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
